Regis Healthcare Ltd. · ASX:REG
Regis Healthcare — Shareholder Meeting (November 2026)
38 slides from Regis Healthcare's shareholder meeting presentation, Nov 17, 2026
Slide 1: Annual General Meeting Presentations ASX Announcement
REGIS HEALTHCARE LIMITED ABN 11 125 203 054 Level 2, 293 Camberwell Road Camberwell, VIC 3124 T: 03 8573 0444 Regis.com.au For personal use only ASX Announcement 17 November 2026 Annual General Meeting Presentations In accordance with Listing Rule 3.13.3, we attach the presentations to be delivered
Slide 2: Chair's Address
CHAIR’S ADDRESS I will now move to the Chair's Address. For personal use only FY26 has been a significant year for Regis and more broadly for the aged care sector. The year marked an important leadership transition for the Company. Following almost seven years as Managing Director and CEO, Linda Mel
Slide 3: Chair's Address (continued)
On homes we operated for the full year, employee turnover reduced from 23% to 18%, leading to a more stable work environment and greater continuity of care for our residents and clients. For personal use only Better staff retention and safety outcomes have delivered financial benefits through lower
Slide 4: Chair's Address: disciplined growth and capital allocation
demand for residential aged care while continuing to deliver attractive returns for shareholders. For personal use only Our approach to growth is disciplined and targeted. We allocate capital across four key areas: greenfield developments, brownfields, refurbishment and redevelopment of existing hom
Slide 5: Chair's Address: aged care demand and bed shortage
of the ageing journey. Demand for residential aged care continues to grow, while waiting lists for support delivered in the home remain significant with over 100,000 waiting for a package. For personal use only At the same time, the development of new residential aged care capacity is not keeping pa
Slide 6: Chair's Address: home care acquisitions
We continue to invest in our existing homes, progress refurbishment programs, improve our For personal use only pricing and selectively pursue expansion opportunities where returns appropriately reflect the capital being deployed. In home care, we have continued to build scale through strategic acqu
Slide 7: Managing Director and CEO AGM Speech 2026
Managing Director and CEO AGM Speech 2026 Thank you Graham and thank you to our shareholders for joining us today. For personal use only Since commencing in July, I have had the pleasure of visiting all 72 of our homes around Australia, spending time with our teams, residents, clients and families.
Slide 8: CEO Speech: quality of care and priorities
Having spent time in each of our 72 homes around Australia, we have excellent people and a high quality portfolio. With operational variability across our network, we have opportunities to For personal use only bring together the best of what we are already doing to further strengthen our quality of
Slide 9: CEO Speech: HELF and realising scale benefits
In recent weeks, we have launched a new simplified Higher Everyday Living Fee (HELF) For personal use only offering and are receiving good feedback from new residents and families. HELF is the government’s approach to allowing providers to provide additional services that are valued by residents but
Slide 10: CEO Speech: acquisitions and Toowong development
On the acquisition front, we believe the current environment will create opportunities for further sector consolidation. The sector remains fragmented with more than 600 residential aged care For personal use only providers nationally. As the regulatory and operating environment becomes more complex
Slide 11: CEO Speech: closing remarks
pursuing disciplined growth. Our focus remains on delivering personalised, quality care for our residents and clients, which will also enable long-term value creation for our shareholders. For personal use only I would like to thank our more than 13,000 team members for their dedication, and care fo
Slide 12: Annual General Meeting November 2026
rsonal use only Annual General Meeting 17 November 2026
Slide 13: Artwork by Charmaine Mumbulla
rsonal use only Artwork by Charmaine Mumbulla
Slide 14: Introduction to Board Directors
Introduction to Board Directors rsonal use only Graham Hodges Andrew Kinkade Sally Freeman Carmel Monaghan Chair and Independent Managing Director and Independent Independent Non-Executive Director Chief Executive Officer Non-Executive Director Non-Executive Director Prof Christine Bennett AO Ian Ro
Slide 15: Agenda
Agenda rsonal use only 1. Chair’s Address 2. CEO’s Address 3. Formal Business 4. Closing
Slide 16: Chair's Address
rsonal use only Chair’s Address
Slide 17: FY26 Results Overview
FY26 Results Overview Underlying EBITDA growth of 10%, ahead of guidance rsonal use only Revenue from Underlying EBITDA1 Underlying NPAT1 Statutory NPAT Services $1,350.6 million $138.0 million $55.6 million $55.7 million +16% on pcp +10% on pcp +4% on pcp +14% on pcp Net Operating Net Cash Underlyi
Slide 18: Operating Earnings and RAD inflows create self-funded growth
Operating Earnings and RAD inflows create self-funded growth Underlying EBITDA + Net RAD Cash Inflow ($m) Strong cash flow rsonal use only Underlying EBITDA + net RAD inflow $388m of internally generated capital 388.5 supports growth and investment 321.2 Higher RADs, EBITDA Targeted investment 248.2
Slide 19: Investing in future Aged Bed capacity
Investing in future Aged Bed capacity The Challenge Priorities for Reform rsonal use only ► Australia's ageing population will require ► Encourage greater consumer contributions where significant new residential aged care capacity individuals have financial capacity over coming decades (10,000 net n
Slide 20: CEO's Address
rsonal use only CEO’s Address
Slide 21: Sector funding pressures impacting access to care
Sector funding pressures impacting access to care Sector funding well below sector costs At the same time, demand is outpacing supply rsonal use only Australians aged 85+1 Projected residential care use1 2.55% $600m+ ~4,000 AN-ACC indexation for Shortfall in funding older Australians reported 411,91
Slide 22: Recap: Key Priorities
Recap: Key Priorities Commenced 20 July; visited 72 homes; priorities remain unchanged following AN-ACC; focus on improving consistency Opportunities to strengthen care and services, Strong platform rsonal use only improve earnings quality and accelerate growth • Excellent team with strong Increasin
Slide 23: Formal Business
Formal Business rsonal use only
Slide 24: Annual Financial Report
Item 1 rsonal use only Annual Financial Report
Slide 25: Re-election and Election of Directors
Item 2 rsonal use only Re-election and Election of Directors 2.1 Graham Hodges 2.2 Carmel Monaghan
Slide 26: Re-election of Graham Hodges
rsonal use only Item 2.1 Re-election of Graham Hodges
Slide 27: Proxy Position: Item 2.1
Proxy Position: Item 2.1 Re-election of Graham Hodges as Director rsonal use only Proxy In Favour Undirected Against Total Valid As a % of Abstain position proxies* Available Issued Open Votes Capital Votes 227,147,750 89,700 5,599,403 232,836,853 76.98% 92 Holders 82 12 15 1 Percentage 97.56% .04%
Slide 28: Election of Carmel Monaghan
rsonal use only Item 2.2 Election of Carmel Monaghan
Slide 29: Proxy Position: Item 2.2
Proxy Position: Item 2.2 Election of Carmel Monaghan as Director rsonal use only Proxy In Favour Undirected Against Total Valid As a % of Abstain position proxies* Available Issued Open Votes Capital Votes 232,664,880 132,994 39,071 232,836,945 76.98% 0 Holders 85 13 9 0 Percentage 99.93% .06% .02%
Slide 30: Adoption of the Remuneration Report
Item 3 rsonal use only Adoption of the Remuneration Report
Slide 31: Proxy Position: Adoption of the Remuneration Report
Proxy Position: Item 3 Adoption of the Remuneration Report rsonal use only Proxy In Favour Undirected Against Total Valid As a % of Abstain position proxies* Available Issued Open Votes Capital Votes 150,476,796 130,094 264,769 150,871,659 49.88% 8,200 Holders 62 12 27 4 Percentage 99.74% .09% .18%
Slide 32: Approval of MD/CEO Sign-on Equity Award
rsonal use only Item 4 Approval of MD/CEO Sign-on Equity Award
Slide 33: Proxy Position: MD/CEO Sign-on Equity Award
Proxy Position: Item 4 Approval of MD/CEO Sign-on Equity Award rsonal use only Proxy In Favour Undirected Against Total Valid As a % of Abstain position proxies* Available Issued Open Votes Capital Votes 149,721,458 130,094 1,054,074 150,905,626 49.89% 81,931,319 Holders 54 12 39 6 Percentage 99.22%
Slide 34: Approval of FY27 grant of Performance Rights to MD/CEO
Item 5 rsonal use only Approval of FY27 grant of Performance Rights to the MD/CEO under the LTI Plan
Slide 35: Proxy Position: FY27 Performance Rights grant
Proxy Position: Item 5 Approval of FY27 grant of Performance Rights to the MD/CEO rsonal use only under the LTI Plan Proxy In Favour Undirected Against Total Valid As a % of Abstain position proxies* Available Issued Open Votes Capital Votes 150,557,608 85,350 262,826 150,905,784 49.89% 81,931,161 H
Slide 36: Meeting Concludes
Meeting Concludes rsonal use only The detailed results of the polls will be announced on the Company’s website and ASX announcement platform later today
Slide 37: Important Information and Disclaimer
Important Information and Disclaimer This Presentation contains summary information about the current activities of Regis Neither Regis Healthcare nor any other person warrants or guarantees the future Healthcare Limited and its controlled entities (Regis Healthcare or the Group). It should performa
Slide 38: Annual General Meeting November 2026
rsonal use only Annual General Meeting 17 November 2026
Regis Healthcare — Shareholder Meeting (November 2026) on 6ix